You are here

Article Text

Article menu
Download PDFPDF
Novel treatment (new drug/intervention; established drug/procedure in new situation)
CASE REPORT
Management of oesophageal intramucosal carcinoma
  1. Darius Ashrafi1,2,
  2. Breda Memon3,
  3. Muhammed Ashraf Memon3
  1. 1Department of Surgery, Sunshine Coast Hospital and Health Service, Birtinya, Queensland, Australia
  2. 2Princess Alexandra Hospital Southside Clinical School, School of Medicine, University of Queensland, Woolloongabba, Brisbane, Queensland, Australia
  3. 3Sunnybank Obesity Centre and South East Queensland Surgery, Brisbane, Queensland, Australia
  1. Correspondence to Dr Darius Ashrafi, darius.ashrafi{at}uqconnect.edu.au

Summary

We present an interesting case of an intramucosal carcinoma (IMC) in the setting of Barrett’s oesophagus in a 66-year-old woman. Her clinical course highlights the shifting paradigm in the approach to management of Barrett’s oesophagus and IMC. With innovation in imaging and endoscopic treatment modalities, patients are detected earlier and managed prior to development of malignancy. The patient was treated with endoscopic modalities, and after 3 years’ follow-up, she remains recurrence free.

  • gastrointestinal surgery
  • general surgery
  • gastric cancer

https://doi.org/10.1136/bcr-2018-224893

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors DA: author of manuscript, literature review and organisation of case. BM: manuscript and linguistic editor. MAM: supervisor, surgeon involved in the case, collector of case files, editor of manuscript.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent Obtained.

    • Provenance and peer review Not commissioned; externally peer reviewed.